Sun Signs $485m Settlement Deal To Close Out Ranbaxy Antitrust Case

Indian Firm’s Ranbaxy Unit Accused Of Submitting Substandard ANDAs

 
• By Dean Rudge
  
Gavel
Sun Bought Ranbaxy In 2014 • Source: Shutterstock: Constantine Pankin

More from Legal & IP

More from Generics Bulletin